ATTENTION: The software behind KU ScholarWorks is being upgraded to a new version. Starting July 15th, users will not be able to log in to the system, add items, nor make any changes until the new version is in place at the end of July. Searching for articles and opening files will continue to work while the system is being updated. If you have any questions, please contact Marianne Reed at mreed@ku.edu .

Show simple item record

dc.contributor.authorHasobe, Masahide
dc.contributor.authorMcKee, James G.
dc.contributor.authorBorchardt, Ronald T.
dc.date.accessioned2015-05-08T15:39:40Z
dc.date.available2015-05-08T15:39:40Z
dc.date.issued1989-06
dc.identifier.citationHaasobe, Masahide, James G. McKee, and Ronald T. Borchardt. "Relationship between Intracellular Concentration of S-Adenosylhomocysteine and Inhibition of Vaccinia Virus Replication and Inhibition of Murine L-929 Cell Growth." Antimicrob. Agents Chemother. June 1989 vol. 33 no. 6 828-834.

http://dx.doi.org/10.1128/AAC.33.6.828
en_US
dc.identifier.urihttp://hdl.handle.net/1808/17658
dc.description.abstract9-(trans-2',trans-3'-Dihydroxycyclopent-4'-enyl)-adenine (compound 1) and -3-deazaadenine (compound 2), which are specific inhibitors of S-adenosylhomocysteine (AdoHcy) hydrolase, were reported earlier by our laboratory (M. Hasobe, J. G. McKee, D. R. Borcherding, and R. T. Borchardt, Antimicrob. Agents Chemother. 31:1849-1851, 1987) to have anti-vaccinia virus activity with reduced murine L-929 cell toxicity compared with the prototype compound neplanocin A. In this study, we showed that the antiviral and cytotoxic effects of compounds 1 and 2 can be related to intracellular concentrations of AdoHey, which are elevated in cells treated with these inhibitors of AdoHcy hydrolase. For example, concentrations of analogs 1 and 2 that produce 50% inhibition of vaccinia virus replication caused only slight elevations in intracellular levels of AdoHcy (from 50 [controls] to 100 to 125 [drug-treated cells] pmol/mg of protein) and elevations in the ratios of AdoHcy/S-adenosylmethionine (from 0.05 to 0.1 [controls] to 0.15 to 0.19 [drug-treated cells]). In contrast to the extreme susceptibility of virus replication to slight elevations in intracellular AdoHcy, cell viability was quite tolerant to higher levels of this metabolite. For example, concentrations of analogs 1 and 2 that produced 50% inhibition of L-929 cell replication caused significant increases in intracellular levels of AdoHcy (to 825 to 950 pmol/mg of protein) and elevations in AdoHcy/S-adenosylmethionine ratios (approximately 1.3). These data make it possible to assign a therapeutic index of 7 to 8 to these compounds on the basis of the comparison of intracellular levels of AdoHcy that caused 50% inhibition of vaccinia virus replication with those that caused 50% inhibition of L-929 cell replication.en_US
dc.description.sponsorshipThis work was supported by a Public Health Service grant from the National Institutes of Health (GM-29332) and a grant from Glaxo, Inc.en_US
dc.publisherThe American Society for Microbiologyen_US
dc.titleRelationship between Intracellular Concentration of S-Adenosylhomocysteine and Inhibition of Vaccinia Virus Replication and Inhibition of Murine L-929 Cell Growthen_US
dc.typeArticle
kusw.kuauthorHasobe, Mashide
kusw.kuauthorMcKee, James G.
kusw.kuauthorBorchardt, Ronald T.
kusw.kudepartmentDepartment of Pharmaceutical Chemistyen_US
dc.identifier.doi10.1128/AAC.33.6.828
kusw.oaversionScholarly/refereed, publisher version
kusw.oapolicyThis item does not meet KU Open Access policy criteria.
dc.rights.accessrightsopenAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record